Dallah Healthcare Co (SAU:4004) Cyclically Adjusted Revenue per Share: ﷼26.41 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4004 Dallah Healthcare Co SAU:4004
87 GF Score
Price ﷼104.00
GF Value ﷼209.36
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Dallah Healthcare Co Cyclically Adjusted Revenue per Share?

Dallah Healthcare Co SAU:4004 +2.06% 87 Cyclically Adjusted Revenue per Share is ﷼26.41 as of Mar. 2026. GuruFocus rates SAU:4004 with a GF Score™ of 87/100 and a GF Value™ of ﷼209.36 (Possible Value Trap). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Dallah Healthcare Co's adjusted revenue per share for the three months ended in Mar. 2026 was ﷼10.025. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ﷼26.41 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Dallah Healthcare Co's average Cyclically Adjusted Revenue Growth Rate was 14.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Dallah Healthcare Co was 15.40% per year. The lowest was 14.10% per year. And the median was 14.75% per year.

As of today (2026-08-10), Dallah Healthcare Co's current stock price is ﷼104.00. Dallah Healthcare Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ﷼26.41. Dallah Healthcare Co's Cyclically Adjusted PS Ratio of today is 3.94.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Dallah Healthcare Co was 10.46. The lowest was 3.86. And the median was 7.09.


Dallah Healthcare Co  (SAU:4004) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Dallah Healthcare Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=104.00/26.41
=3.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Dallah Healthcare Co was 10.46. The lowest was 3.86. And the median was 7.09.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Dallah Healthcare Co Cyclically Adjusted Revenue per Share Related Terms


Dallah Healthcare Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Dallah Healthcare Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dallah Healthcare Co Cyclically Adjusted Revenue per Share Chart

Dallah Healthcare Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.47 17.08 19.59 22.24 25.37

Dallah Healthcare Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.03 23.91 24.79 25.37 26.41

SAU:4004 vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Dallah Healthcare Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dallah Healthcare Co Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Dallah Healthcare Co's Cyclically Adjusted PS Ratio falls into.


SAU:4004
87GF Score
Dallah Healthcare Co SAU:4004
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dallah Healthcare Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dallah Healthcare Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=10.025/330.2130*330.2130
=10.025

Current CPI (Mar. 2026) = 330.2130.

Dallah Healthcare Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 3.204 241.018 4.390
201609 3.035 241.428 4.151
201612 3.514 241.432 4.806
201703 3.364 243.801 4.556
201706 3.202 244.955 4.316
201709 3.281 246.819 4.390
201712 3.621 246.524 4.850
201803 3.429 249.554 4.537
201806 3.035 251.989 3.977
201809 3.122 252.439 4.084
201812 3.536 251.233 4.648
201903 3.571 254.202 4.639
201906 3.261 256.143 4.204
201909 3.524 256.759 4.532
201912 3.884 256.974 4.991
202003 3.679 258.115 4.707
202006 2.895 257.797 3.708
202009 4.102 260.280 5.204
202012 4.617 260.474 5.853
202103 5.496 264.877 6.852
202106 5.454 271.696 6.629
202109 6.046 274.310 7.278
202112 6.395 278.802 7.574
202203 6.771 287.504 7.777
202206 6.487 296.311 7.229
202209 6.677 296.808 7.428
202212 7.710 296.797 8.578
202303 7.441 301.836 8.141
202306 6.863 305.109 7.428
202309 7.676 307.789 8.235
202312 8.251 306.746 8.882
202403 8.027 312.332 8.487
202406 7.836 314.175 8.236
202409 8.697 315.301 9.108
202412 8.308 315.605 8.693
202503 8.528 319.799 8.806
202506 10.499 322.561 10.748
202509 10.487 324.800 10.662
202512 10.608 324.054 10.810
202603 10.025 330.213 10.025

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ﷼26.41 mean?
Dallah Healthcare Co (SAU:4004) has a Cyclically Adjusted Revenue per Share of ﷼26.41 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Dallah Healthcare Co and its competitors.
Is Dallah Healthcare Co's Cyclically Adjusted Revenue per Share too high?
Dallah Healthcare Co's current Cyclically Adjusted Revenue per Share is ﷼26.41. Overall, Dallah Healthcare Co has a GF Score™ of 87/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Dallah Healthcare Co's Cyclically Adjusted Revenue per Share of ﷼26.41 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Dallah Healthcare Co and its competitors. Dallah Healthcare Co's current Cyclically Adjusted Revenue per Share is ﷼26.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼209.36, compared to a current price of ﷼104.00 — trading 50.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ﷼26.41. Dallah Healthcare Co's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current Cyclically Adjusted Revenue per Share is ﷼26.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?

Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued. The current stock price of ﷼104.00 is trading 50.3% below its estimated GF Value™ of ﷼209.36. GuruFocus considers Dallah Healthcare Co to be Possible Value Trap.

Key valuation signals for SAU:4004:

  • Cyclically Adjusted Revenue per Share: ﷼26.41
  • GF Value™: ﷼209.36 vs. price of ﷼104.00 (50.3% below fair value)
  • GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dallah Healthcare Co Business Description

Address 1157 King Fahad Road, Nakheel building, 2nd Floor, Riyadh, SAU, 12381
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
87GF Score

Get the complete analysis for SAU:4004

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼104.00
Price
﷼209.36
GF Value